Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
07/2005
07/05/2005US6913629 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces
07/05/2005CA2344647C New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
07/05/2005CA2230082C Amide compounds and use thereof
07/05/2005CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients
06/2005
06/30/2005WO2005058804A1 Process for the preparation of tertiary amines attached to a secondary carbon centre
06/30/2005WO2005016277A3 Arylsulfonamidobenzylic compounds
06/30/2005US20050143541 Water- and oil-repellent fluoroacrylates
06/30/2005US20050143454 Friedel-Crafts alkylation of the 2-haloaniline under milder conditions by protecting the amine as a carbamate by reaction with an alkyl chloroformate; regioselectivity for the 4-phenyl position; intermediates for drugs or agricultural chemicals as 6-t-butyl-8-fluoroquinoline rice blast control agents
06/30/2005US20050143352 Substituted tetracycline compounds
06/29/2005EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1546086A2 Aminoalcohol derivatives
06/29/2005CN1208329C Aniline derivatives
06/23/2005WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof
06/23/2005WO2005055959A2 Bulky monomers leading to resins exhibiting low polymerization shrinkage
06/23/2005WO2005037784A3 Crystalline form of gamma-aminobutyric acid analog
06/23/2005WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes
06/23/2005WO2002068380A8 Synthetic excitatory amino acids
06/23/2005US20050137421 Method for making fluorine labled L-Dopa
06/23/2005US20050137236 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137174 Broad spectrum antibiotics; N-t-Butylcarbonyloxymethyl (9-[(2,2, dimethyl-propyl amino)-methyl]-minocycline)carbamate; antiinflammatory, anticarcinogenic, viricde, bactericide; gram positive and gram negative bacterial infection; viral infection; prodrugs
06/22/2005EP1326711B1 Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005CN1630634A Optically active 2, 5-bisaryl-delta1-pyrrolines and their use as pest control agents
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1207268C Novel derivatives of 3-3-diphenylpropylamines
06/21/2005US6909005 One post synthesis of 2-oxazolidinone derivatives
06/21/2005US6908957 Curable electron donor compounds
06/21/2005CA2345019C Hydroxyl functional urethanes having a tertiary carbamate bond
06/16/2005WO2005054186A2 Methods for the preparation of stereoisomerically enriched amines
06/16/2005WO2005054176A1 Peroxisome proliferator activated receptor modulators
06/16/2005WO2005030135A3 Nitrosated glutamic acid compounds, compositions and methods of use
06/16/2005WO2005010011A3 Methods of synthesis of acyloxyalkyl compounds
06/16/2005WO2005009943A3 Substituted tetracycline compounds
06/16/2005US20050131231 Process for preparing cyclic N-substituted alpha-imino carboxlic acids
06/16/2005US20050131075 Method of preparing retroviral protease inhibitor intermediates
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130936 N-protected epoxide intermediate for making various hydroxyethylamine Alzheimer's drugs such as N1-{(1S,2R)-1-benzyl-3-[(3,5-difluorobenzyl)amino]-2-hydroxypropyl}-N3, N3-dipropylisophthalamide
06/16/2005CA2549289A1 Methods for the preparation of stereoisomerically enriched amines
06/16/2005CA2547212A1 Peroxisome proliferator activated receptor modulators
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539682A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1095027B1 Substituted phenyl uracils
06/15/2005EP1064252B1 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
06/15/2005CN1628097A Astaxanthin esters
06/15/2005CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
06/15/2005CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
06/15/2005CN1206212C Tri-substd. phenyl derivs. and analogues
06/15/2005CN1206210C Ethyl methyl 3-[(1S)-1-(dimethylamino)ethyl]phenyl] carbamate and its prepn and medicine use
06/14/2005US6906224 Process for producing α-aminoketones
06/14/2005US6906171 Process for the deprotection of protected thiols
06/14/2005US6905297 Locking nut, bolt and clip systems and assemblies
06/14/2005CA2255543C Solid vinyl ether terminated urethane curing agent
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005WO2005051895A1 Organic compounds
06/09/2005US20050124831 Process for producing beta-aminoketone and catalyst therefor
06/09/2005US20050124721 Bulky monomers leading to resins exhibiting low polymerization shrinkage
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
06/09/2005US20050123475 Preparation and use of alkylating agents
06/09/2005DE10351904A1 Verfahren zur Herstellung von cyclischen N-substituierten alpha-Iminocarbonsäure A process for the preparation of cyclic N-substituted alpha-iminocarboxylic acid
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1537125A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
06/08/2005EP1537070A1 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
06/08/2005EP1537066A2 Improvements in pharmaceutically useful compounds
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1623980A Method for preparing optical pure N-tertiary butyl oxycarbonyl-beta-difluorine phenylalanine
06/08/2005CN1623977A Method of preparing retroviral protease inhibitor intermediates
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005CA2051693C Allosteric hemoglobin modifiers
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/01/2005EP1535902A1 Aminoindan derivatives
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/31/2005US6900213 Controlling fertility; contraceptives; anticancer agents
05/26/2005WO2005047263A1 Method for producing cyclic, n-substituted alpha-iminocarboxylic acids
05/26/2005WO2005047234A1 Method for producing carbamate group-containing (meth)acrylic esters
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes
05/26/2005US20050113400 Novel benzophenone derivatives or salts thereof
05/26/2005US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis
05/25/2005EP1532098A1 Process for preparing nitrooxyderivatives of naproxen
05/25/2005DE10349971A1 Production of (meth)acrylate esters with carbamate groups, for use e.g. in functionalization of polymers, involves reacting hydroxy-carbamate compounds with (meth)acrylic anhydride in presence of inhibitor and acid catalyst
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620425A Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates
05/24/2005US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
05/24/2005US6897236 Aminobenzophenones as inhibitors of IL-1β and TNF-α
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 157